Evaxion Biotech AS (EVAX)
2.64
+0.05
(+1.93%)
USD |
NASDAQ |
Nov 04, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Profit Margin (Quarterly): -64.14% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -64.14% |
| June 30, 2024 | -4.02K% |
| Date | Value |
|---|---|
| March 31, 2024 | |
| December 31, 2023 | -6.20K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.20K%
Minimum
Dec 2023
-64.14%
Maximum
Sep 2024
-3.43K%
Average
-4.02K%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| Ascendis Pharma AS | -303.9% |
| Novo Nordisk AS | 29.46% |
| DBV Technologies SA | -- |
| Adaptimmune Therapeutics PLC | 54.22% |
| Akari Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -69.51% |
| Return on Invested Capital | -239.0% |
| Operating Margin (Quarterly) | -57.37% |